LFM-A13 is a potent BTK, JAK2, PLK inhibitor, inhibits recombinant BTK, Plx1 and PLK3 with IC50s of 2.5 µM, 10 µM and 61 µM, LFM-A13 shows no effects on JAK1 and JAK3, Src family kinase HCK, EGFR and IRK.
Molecular Weight:
360.01
Purity:
99.80
CAS Number:
[244240-24-2]
Formula:
C11H8Br2N2O2
Target:
Btk,JAK,Polo-like Kinase (PLK)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
